Journal
DRUG DISCOVERY TODAY
Volume 24, Issue 5, Pages 1139-1147Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2019.03.013
Keywords
-
Categories
Funding
- National Institute of Neurological Disorders and Stroke of the National Institutes of Health [1R01NS102164-01]
- NIH NINDS [1R01NS102164-01]
- RFBR [17-54-30007]
Ask authors/readers for more resources
Recent estimates suggest close to one million people per year die globally owing to HIV-related illnesses. Therefore, there is still a need to identify new targets to develop future treatments. Many of the more recently identified targets are host-related and these might be more difficult for the virus to develop drug resistance to. In addition, there are virus-related targets (capsid and RNAse H) that have yet to be exploited clinically. Several of the newer targets also address virulence factors, virus latency or target persistence. The targets highlighted in this review could represent the next generation of viable candidates for drug discovery projects as well as continue the search for a cure for this disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available